Главная
Study mode:
on
1
Introduction
2
Overview
3
Risk Factors
4
Over Diagnosis
5
Indeterminate biopsy
6
Patient story
7
What is molecular testing
8
Principles of testing
9
First molecular test
10
First molecular test examples
11
Second molecular test
12
Examples
13
How molecular testing avoids unnecessary surgery
14
UCLA experience with molecular testing
15
Current practice at UCLA
16
Study results
17
Prognosis
18
Avoid surgery
19
Summary
20
Questions
Description:
Explore the latest advancements in thyroid cancer diagnosis with UCLA endocrine surgeons Dr. Michael Yeh and Dr. Masha Livhits in this informative 43-minute webinar. Gain insights into molecular approaches for diagnosing thyroid cancer, focusing on molecular markers as valuable tools for assessing indeterminate thyroid nodules. Learn about risk factors, over-diagnosis concerns, and the principles of molecular testing. Discover how these innovative techniques can help avoid unnecessary surgeries, and understand UCLA's current practices and study results in this field. Delve into patient stories, prognosis considerations, and participate in a Q&A session to enhance your understanding of this crucial topic in endocrine surgery.

Molecular Markers for Thyroid Cancer - Masha Livhits, MD & Michael Yeh, MD - UCLAMDChat

University of California, Los Angeles
Add to list
0:00 / 0:00